Health

HHS Seeks Rensselaer Research on Autism-Vaccine Links

HHS Seeks Rensselaer Research on Autism-Vaccine Links - News Directory 3

CDC to Fund Research into Debunked Vaccine-Autism Link,⁢ Reviving Trump-Era initiative

Published September 12, 2025, at 18:34:07 EDT. Updated as needed.

What Happened

The Centers for ⁣Disease Control and prevention (CDC) announced on Thursday, September 11, 2025, its intention to fund research investigating a previously ‍debunked link between vaccines and autism prevalence. The contract, initially ⁢solicited during ⁣the Trump administration, will be ⁣awarded to⁤ Rensselaer Polytechnic Institute (RPI) if finalized. This marks a significant shift, reviving a line of inquiry widely dismissed by the scientific community.

The⁤ contract chance, posted on SAM.gov,⁢ details the research ‍focus.‍ It aims to explore the association between vaccination and autism prevalence,despite extensive evidence demonstrating no causal relationship.

Why It Matters: A History ‍of Discredited Claims

The pursuit⁤ of a link ‍between vaccines and autism dates back to⁢ a 1998⁣ paper published⁤ in The Lancet by Andrew Wakefield. This ⁢paper, later retracted by the journal and widely discredited due to fraudulent data⁣ and ‍ethical violations, falsely claimed a connection between the measles, ⁤mumps, and rubella (MMR) vaccine and autism. ‍ Wakefield lost his medical license as a result.

Numerous studies conducted as then have consistently refuted ⁢any link between vaccines and autism.Organizations like the CDC, the World Health Organization (WHO), and the American⁤ Academy of Pediatrics⁤ (AAP) all affirm the ⁢safety and efficacy of vaccines and their lack of association with ⁤autism. Despite this consensus, the myth persists, fueled by misinformation and anti-vaccine sentiment.

Sole-Source Contract: Why RPI?

The contract is⁣ a sole-source‍ award, meaning RPI was not required to ‍compete with other institutions for the funding. This typically occurs when the goverment believes a specific⁤ institution possesses unique expertise or resources necessary for the research. The contract details suggest RPI has ⁢specific capabilities in analyzing large datasets related to vaccine ‍and autism prevalence.

While sole-source contracts can be justified in certain circumstances, they raise concerns about transparency⁢ and potential bias.Critics argue that awarding the‍ contract without competition could prioritize⁣ a specific research agenda over broader scientific consensus.

Contract detail Information
Agency Centers for Disease Control⁤ and Prevention (CDC)
Recipient Rensselaer Polytechnic Institute (RPI)
Contract Type Sole-Source
Research⁢ Focus Association between vaccination and autism prevalence
Contract Opportunity ID 280398e7b4b54c0fac7de5efcbb80a80

expert Analysis

Timeline of‍ the Vaccine-Autism Debate